Results

Total Results: 2,173 records

Showing results for "medications".
Users also searched for: medication reconciliation

321. S158 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
     October 01, 2007 - Nevertheless, random- ized controlled trials have major limitations when they are used to assess the role of medications … it is possible to include a wide variety of participants and assess long-term exposures, in- cluding medications … With respect to prescribed medications, this bias is called confounding by indication.2 It stems from … The potential for confounding is probably larger in observational studies assessing medications than … visits† 1.3 1.3–1.3 1.1 1.0–1.4 1.1 0.9–1.3 No. hospitalizations† 0.9 0.9–0.9 1.1 0.9–1.3 1.0 0.9–1.2 Medications

322. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
     September 01, 2009 - Medications available for lipid-lowering therapy have various mechanisms of action and pharmacokinetic … Statins are the most studied and prescribed group of lipid-lowering medications and may be used alone … Combining different types of medications may appear attractive but could result in more harms, be less … combinations would also be of some interest, although the potential for BAS to interact with other medications … In studies employing a mixture of statin medications and/or doses, results should be reported by medication

323. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Therefore, physicians may also recommend weight-loss medication.40 If goals are not achieved with medications … Diet and exercise and currently available medications are ineffective in long-term weight loss. … clinical guidelines on using pharmacology to manage obesity suggest using FDA-approved weight-loss medications … Despite the limitations and concerns, this is a novel agent in the overall paucity of antiobesity medications … Clinical policy bulletin no. 0039: weight reduction medications and programs. [internet].

324. Crosscutting-Horizon-Scan-High-Impact-1406 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - smart-pill” technology or “digital medicine,” has been developed for use with oral pill or capsule medications … The company is working with selected pharmaceutical manufacturers to choose medications for sensor … At a postdischarge visit, typical activities are as follows: the discharge worker reconciles medications … medication of interest.”36,37 Patients can ingest up to 30 sensors per day.38 Patients take oral medications … At the postdischarge visit, the discharge worker reconciles medications, reviews medication use, arranges

325. Topic 0586 LUTS Secondary to BPH NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0713-140625.pdf
     January 07, 2014 - . § Common medications for LUTS/BPH include alpha-blockers, beta-3 agonists, anticholinergic agents

326. Topic Coming Back CER 28 DMARDs in Children with JIA NSD _SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
     March 27, 2014 - Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications

327. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
     October 01, 2014 -   Bipolar Depression and Major Depressive Disorder  Key Facts: Despite widespread use, approved medications … Only a fraction of treated patients respond within a week of starting any of the many medications available … Food and Drug Administration (FDA) for treating PMD.3 Effective medications are needed for this condition … typically the first-line treatment and involves concomitant use of antidepressant and antipsychotic medications … Unmet need and health outcomes: An extremely important unmet need exists for rapidly effective medications

328. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update--Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
     January 01, 2018 - and Young Adults: Systematic Review Update Executive Summary Introduction The use of psychotropic medications … Exclusion of non-antipsychotic medications as comparator. … Only one study permitted concomitant psychotropic medications including stimulants. … Treatment of young people with antipsychotic medications in the United States. … Medicaid prior authorization policies for pediatric use of antipsychotic medications.

329. Strategies To Prevent Weight Gain in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-future_research.pdf
     January 01, 2020 - What is the comparative effectiveness of medications for the prevention of weight gain among adults? … KQ4 What is the comparative effectiveness of medications for the prevention of weight gain among adults … or insulin, given their high risk of weight gain, attributed in part to side effects from these medications … The majority of stakeholders identified medications as the lowest priority strategies for weight gain … Stakeholders commented that they ranked medications lower due to concerns about the long- term viability

330. Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol-final.pdf
     October 15, 2024 - will require understanding moderators in the receipt of menopause therapy, including the cost of medications … bioidenticals, testosterone, and hormonal contraceptives, we will limit inclusion to FDA- approved medications … For testosterone and hormonal contraceptives, we will limit to FDA- approved medications. … For testosterone and hormonal contraceptives, we will limit to FDA- approved medications. … b Topic medications are excluded: Vaginal ring (Estring 7.5 mcg estradiol per day released over 3 months

331. Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol.pdf
     October 15, 2024 - will require understanding moderators in the receipt of menopause therapy, including the cost of medications … bioidenticals, testosterone, and hormonal contraceptives, we will limit inclusion to FDA- approved medications … For testosterone and hormonal contraceptives, we will limit to FDA- approved medications. … For testosterone and hormonal contraceptives, we will limit to FDA- approved medications. … b Topic medications are excluded: Vaginal ring (Estring 7.5 mcg estradiol per day released over 3 months

332. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Thus, an unmet need has existed for novel, effective medications to improve outcomes in this patient … They also use inhaled medications, ventilators, and chest physiotherapy singly or in combination to … Treatment includes smoking-cessation counseling and nicotine-addiction treatment, medications to address … Available: http://www.onlinepharmacycatalog.com/drugs- medications/antibiotics/azithromycin/zithromax … Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

333. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_executive.pdf
     April 01, 2011 - The clearest evidence favors the use of medications to address challenging behaviors. … Both medications also cause significant side effects, however, including marked weight gain, sedation … We rated the strength of evidence as high for the adverse effects of both medications, moderate for the … For medical studies, data across classes of medications are likely to be transferable outside of the … A few medications show benefit for repetitive behaviors or associated symptoms, with the clearest evidence

334. CER 229 Evidence Summary: Opioid Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
     April 01, 2020 - • At short-term followup, evidence showed no differences between opioids versus nonopioid medications … In the United States, prescription of opioid medications for chronic pain more than tripled from 1999 … prescription of long-acting opioids associated with increased risk of all-cause mortality vs. nonopioid medications … increased risk of overdose, 16 with most pronounced risk occurring soon after initiation of these medications … All-cause and drug-related medical events associated with overuse of gabapentin and/or opioid medications

335. Peripheral-Artery-Disease-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
     May 01, 2013 - The review was designed to evaluate the effectiveness of available strategies—exercise, medications, … What is the comparative effectiveness of exercise training, medications (cilostazol, pentoxifylline) … Scientific information packets were requested from the manufacturers of medications and devices and … For KQ 1, this consisted of studies of all PAD populations comparing antiplatelet medications (aspirin … For KQ 2, this consisted of studies of PAD patients with IC comparing exercise therapy, medications

336. Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
     January 01, 2024 - without modifiable CV risk factors, including o Dyslipidemia (including if taking lipid- lowering medications … (≥18 years old) Both Key Questions ● Participants with a health-related condition or taking medications … that impact fat absorption, fat metabolism ● Participants taking weight loss medications, including

337. Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular Events (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
     January 01, 2024 - without modifiable CV risk factors, including o Dyslipidemia (including if taking lipid lowering medications … (≥18 years old) Both Key Questions ● Participants with a health-related condition or taking medications … that impact fat absorption, fat metabolism ● Participants taking weight loss medications, including

338. Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
     January 01, 2024 - Anticoagulation medications help prevent life-threatening events such as pulmonary embolism, but they … Regarding specific anticoagulants, one of the touted advantages of newer DOAC medications (e.g., apixaban … However, the newer medications still require careful dosing and monitoring. … The first, Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation … Second, a series of open- ended questions to assess patient understanding of medications and VTE

339. Weight-Gain-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
     January 01, 2020 - Obesity can also be caused by medications used to treat chronic disease, as is the case for antipsychotic … Diabetes and some cancer medications are also associated with weight gain. … Interventions for patients initiating diabetes medications, tamoxifen, and aromatase inhibitors are … Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update [Internet]. … Diabetes medications and body weight. Expert Opin Drug Saf. 2009;8(5):573-84.

340. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
     September 01, 2011 - Layout 1 Background Antipsychotics medications are approved by the U.S. … These medications are commonly divided into two classes, reflecting two waves of historical development … for decades, the conventional antipsychotics also produced various side effects requiring additional medications … This report covers the following off-label uses of atypical antipsychotic medications: anxiety, ADHD, … Sub-Key Question 2: How do atypical antipsychotic medications compare with other drugs, including first